Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 2 (2005), Issue 3 (March)

1. Risk of puerperal and non-puerperal recurrence of illness following bipolar affective puerperal (post-partum) psychosis.
   Br J Psychiatry, 186: 258-9. [Abstract] [Full-text]
2. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.
   Biol Psychiatry, 57(5): 525-32. [Abstract] [Full-text]
3. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder.
   Mol Psychiatry, 10(3): 309-22. [Abstract] [Full-text]
4. Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994-2003.
   J Child Adolesc Psychopharmacol, 15(1): 26-37. [Abstract] [Full-text]
5. Concomitant pharmacotherapy among youths treated in routine psychiatric practice.
   J Child Adolesc Psychopharmacol, 15(1): 12-25. [Abstract] [Full-text]
6. Assessing the community prevalence of bipolar spectrum symptoms by the mood disorder questionnaire.
   Psychother Psychosom, 74(2): 120-2. [Abstract] [Full-text]
7. Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study.
   Psychother Psychosom, 74(2): 113-9. [Abstract] [Full-text]
8. Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder.
   Am J Psychiatry, 162(3): 616-8. [Abstract] [Full-text]
9. Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium.
   Pharmacopsychiatry, 38(2): 105-6. [Abstract] [Full-text]
10. The genetics of schizophrenia and bipolar disorder: dissecting psychosis.
    J Med Genet, 42(3): 193-204. [Abstract] [Full-text]
11. Gender differences in the effects of family adversity on the risk of onset of DSM-III-R social phobia.
    J Anxiety Disord, 19(5): 479-502. [Abstract] [Full-text]
12. Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole.
    Drugs Today (Barc), 41(1): 5-11. [Abstract] [Full-text]
13. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease.
    Gen Hosp Psychiatry, 27(2): 133-9. [Abstract] [Full-text]
14. Barriers to the effective management of bipolar disorder: a survey of psychiatrists based in the UK and USA.
    Bipolar Disord, 7: 38-42. [Abstract] [Full-text]
15. The burden on informal caregivers of people with bipolar disorder.
    Bipolar Disord, 7: 25-32. [Abstract] [Full-text]
16. Women are not the same as men: specific clinical issues for female patients with bipolar disorder.
    Bipolar Disord, 7: 16-24. [Abstract] [Full-text]
17. Assessment tools for screening and monitoring bipolar disorder.
    Bipolar Disord, 7: 8-15. [Abstract] [Full-text]
18. An investigation of prepulse inhibition in pediatric bipolar disorder.
    Bipolar Disord, 7(2): 198-203. [Abstract] [Full-text]
19. Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy.
    Bipolar Disord, 7(2): 192-7. [Abstract] [Full-text]
20. Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence.
    Bipolar Disord, 7(2): 187-91. [Abstract] [Full-text]
21. Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder.
    Bipolar Disord, 7(2): 176-86. [Abstract] [Full-text]
22. Spontaneous and directed application of verbal learning strategies in bipolar disorder and obsessive-compulsive disorder.
    Bipolar Disord, 7(2): 166-75. [Abstract] [Full-text]
23. Quality of life for patients with bipolar disorder: relationship with clinical and demographic variables.
    Bipolar Disord, 7(2): 159-65. [Abstract] [Full-text]
24. Developmental abnormalities in striatum in young bipolar patients: a preliminary study.
    Bipolar Disord, 7(2): 153-8. [Abstract] [Full-text]
25. Expression of mitochondria-related genes in lymphoblastoid cells from patients with bipolar disorder.
    Bipolar Disord, 7(2): 146-52. [Abstract] [Full-text]
26. Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia.
    Bipolar Disord, 7(2): 136-45. [Abstract] [Full-text]
27. Use of mental health and primary care services by caregivers of patients with bipolar disorder: a preliminary study.
    Bipolar Disord, 7(2): 126-35. [Abstract] [Full-text]
28. Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentation.
    Bipolar Disord, 7(2): 119-25. [Abstract] [Full-text]
29. Age at onset in bipolar affective disorders: a review.
    Bipolar Disord, 7(2): 111-8. [Abstract] [Full-text]
30. Postnatal euphoria: are 'the highs' an indicator of bipolarity?
    Bipolar Disord, 7(2): 103-10. [Abstract] [Full-text]
31. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Clin Infect Dis, 40: S286-91. [Abstract] [Full-text]
32. Diagnostic stability in depressive disorder as according to ICD-10 in clinical practice.
    Psychopathology, 38(1): 32-7. [Abstract] [Full-text]
33. Temporal stability of the dex/CRH test in patients with rapid-cycling bipolar I disorder: a pilot study.
    Aust N Z J Psychiatry, 39(4): 244-8. [Abstract] [Full-text]
34. Mania in the Swedish Twin Registry: criterion validity and prevalence.
    Aust N Z J Psychiatry, 39(4): 235-43. [Abstract] [Full-text]
35. Neuropsychological disturbances and cerebral blood flow in bipolar disorder.
    Aust N Z J Psychiatry, 39(4): 227-34. [Abstract] [Full-text]
36. Anatomical MRI abnormalities in bipolar disorder: do they exist and do they progress?
    Aust N Z J Psychiatry, 39(4): 222-6. [Abstract] [Full-text]
37. 'Bipolar missed states': the diagnosis and clinical salience of bipolar mixed states.
    Aust N Z J Psychiatry, 39(4): 215-21. [Abstract] [Full-text]
38. Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study.
    Biol Psychiatry, 57(6): 633-9. [Abstract] [Full-text]
39. Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats.
    Biol Psychiatry, 57(6): 571-6. [Abstract] [Full-text]
40. Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.
    J Affect Disord, 85(3): 341-50. [Abstract] [Full-text]
41. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder.
    J Affect Disord, 85(3): 301-15. [Abstract] [Full-text]
42. Diagnostic stability in bipolar disorder in clinical practise as according to ICD-10.
    J Affect Disord, 85(3): 293-9. [Abstract] [Full-text]
43. Divalproex in the treatment of bipolar depression: a placebo-controlled study.
    J Affect Disord, 85(3): 259-66. [Abstract] [Full-text]
44. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    J Affect Disord, 85(3): 245-58. [Abstract] [Full-text]
45. The theoretical underpinnings of affective temperaments: implications for evolutionary foundations of bipolar disorder and human nature.
    J Affect Disord, 85(1): 231-9. [Abstract] [Full-text]
46. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    J Affect Disord, 85(1): 217-30. [Abstract] [Full-text]
47. Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls.
    J Affect Disord, 85(1): 207-15. [Abstract] [Full-text]
48. Temperament profiles in physicians, lawyers, managers, industrialists, architects, journalists, and artists: a study in psychiatric outpatients.
    J Affect Disord, 85(1): 201-6. [Abstract] [Full-text]
49. Cyclothymic temperament as a prospective predictor of bipolarity and suicidality in children and adolescents with major depressive disorder.
    J Affect Disord, 85(1): 181-9. [Abstract] [Full-text]
50. Familiality of temperament in bipolar disorder: support for a genetic spectrum.
    J Affect Disord, 85(1): 153-68. [Abstract] [Full-text]
51. A comparison of recovered bipolar patients, healthy relatives of bipolar probands, and normal controls using the short TEMPS-A.
    J Affect Disord, 85(1): 147-51. [Abstract] [Full-text]
52. The cyclothymic temperament in healthy controls and familially at risk individuals for mood disorder: endophenotype for genetic studies?
    J Affect Disord, 85(1): 135-45. [Abstract] [Full-text]
53. Affective temperaments as measured by TEMPS-A in patients with bipolar I disorder and their first-degree relatives: a controlled study.
    J Affect Disord, 85(1): 127-33. [Abstract] [Full-text]
54. Affective temperaments in clinically-well subjects in Turkey: initial psychometric data on the TEMPS-A.
    J Affect Disord, 85(1): 113-25. [Abstract] [Full-text]
55. Temperament and job stress in Japanese company employees.
    J Affect Disord, 85(1): 101-12. [Abstract] [Full-text]
56. Reliability and validity of TEMPS-A in a Japanese non-clinical population: application to unipolar and bipolar depressives.
    J Affect Disord, 85(1): 85-92. [Abstract] [Full-text]
57. Studies on a German (Münster) version of the temperament auto-questionnaire TEMPS-A: construction and validation of the briefTEMPS-M.
    J Affect Disord, 85(1): 53-69. [Abstract] [Full-text]
58. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament.
    J Affect Disord, 85(1): 45-52. [Abstract] [Full-text]
59. Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study.
    J Affect Disord, 85(1): 29-36. [Abstract] [Full-text]
60. The relationship of Kraepelian affective temperaments (as measured by TEMPS-I) to the tridimensional personality questionnaire (TPQ).
    J Affect Disord, 85(1): 17-27. [Abstract] [Full-text]
61. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire.
    J Affect Disord, 85(1): 3-16. [Abstract] [Full-text]
62. Biomedical applications of 7Li NMR.
    NMR Biomed, 18(2): 67-73. [Abstract] [Full-text]
63. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.
    Am J Med Genet B Neuropsychiatr Genet, 134(1): 60-6. [Abstract] [Full-text]
64. Association analysis of transcripts from the bipolar susceptibility locus on chromosome 4q35, exclusion of a pathogenic role for eight positional candidate genes.
    Am J Med Genet B Neuropsychiatr Genet, 134(1): 56-9. [Abstract] [Full-text]
65. A48G polymorphism in the D1 receptor genes associated with bipolar I disorder.
    Am J Med Genet B Neuropsychiatr Genet, 134(1): 37-8. [Abstract] [Full-text]
66. Genetic linkage of bipolar disorder to chromosome 6q22 is a consistent finding in Portuguese subpopulations and may generalize to broader populations.
    Am J Med Genet B Neuropsychiatr Genet, 134(1): 119-21. [Abstract] [Full-text]
67. Exclusion of non-synonymous SNPs and a polyglutamine tract in SMRT/N-CoR2 as common deleterious mutation for bipolar disorder in the Sagnenay-Lac-St-Jean population.
    Am J Med Genet B Neuropsychiatr Genet, 134(1): 10-2. [Abstract] [Full-text]
68. Distinctions between bipolar and unipolar depression.
    Clin Psychol Rev, 25(3): 307-39. [Abstract] [Full-text]
69. The treatment of mixed states and the risk of switching to depression.
    Eur Psychiatry, 20(2): 96-100. [Abstract] [Full-text]
70. New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder.
    Eur Psychiatry, 20(2): 92-5. [Abstract] [Full-text]
71. Update on the treatment of bipolar disorder in children and adolescents.
    Eur Psychiatry, 20(2): 87-91. [Abstract] [Full-text]
72. Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex.
    Neuron, 45(6): 861-72. [Abstract] [Full-text]
73. Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode.
    Am J Psychiatry, 162(4): 799-802. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.